Saturn V Capital Management »

Vaxcyte shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $13M 185k 68.31

More positions owned by Saturn V Capital Management

Crinetics Pharmaceuticals In (CRNX)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Kalvista Pharmaceuticals (KALV)
Merus N V (MRUS)
Disc Medicine (IRON)
Ascendis Pharma A/s Sponsored Adr (ASND)
Anaptysbio Inc Common (ANAB)
Vaxcyte (PCVX)
Cogent Biosciences (COGT)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
Syndax Pharmaceuticals (SNDX)
Abivax Sa Sponsored Ads (ABVX)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Saturn V Capital Management

Top funds holding Vaxcyte

FMR
Vanguard Group
BlackRock
RA Capital Management
Henderson Group
Wellington Management Company
T. Rowe Price Investment Management
T. Rowe Price Associates
Darwin Global Management
Geode Capital Management
Franklin Resources
Perceptive Advisors
Alliancebernstein
Westfield Capital Management Company
Fred Alger Management

View all funds holding Vaxcyte